Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study.

So far (and the data are entirely preliminary and debatable), we also detected a statistical trend toward a better prognosis with R/T sequential therapy vs. the T/R sequence, in patients with wt RAS tumors, ECOG PS = 0–1, hepatic metastases only, in men and in patients younger than 70 years.

also in 2,798 other papers